Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,849,752
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271,000 K
  • 60-Month Beta 1.70
  • Price/Sales 4.06
  • Price/Cash Flow 5.41
  • Price/Book 1.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
186.50 +7.32%
on 01/31/20
202.21 -1.02%
on 02/12/20
+7.57 (+3.93%)
since 01/21/20
3-Month
183.40 +9.13%
on 11/22/19
202.21 -1.02%
on 02/12/20
+15.61 (+8.46%)
since 11/21/19
52-Week
114.27 +75.16%
on 06/17/19
202.21 -1.02%
on 02/12/20
+63.55 (+46.52%)
since 02/21/19

Most Recent Stories

More News
Aerie's (AERI) Q4 Loss Wider Than Expected, Revenues Beat

Aerie (AERI) reports a wider loss in the fourth quarter, while sales surpass expectations.

PFE : 35.72 (-0.36%)
AGN : 200.15 (+0.71%)
AERI : 21.59 (+8.55%)
BHC : 26.50 (+0.34%)
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

CVX : 109.01 (-0.73%)
CVS : 71.51 (-0.60%)
AGN : 200.15 (+0.71%)
OXY : 42.12 (-1.98%)
ABBV : 94.96 (+0.77%)
BTL Files Lawsuit against Allergan for False Advertising and Unfair Competition

BTL Industries, Inc. ("BTL") today announced it has filed a lawsuit against Allergan plc, Allergan USA, Inc., Allergan, Inc., and Zeltiq Aesthetics, Inc. The lawsuit alleges a wide-ranging false and misleading...

AGN : 200.15 (+0.71%)
One of Your Stock Investments is Being Acquired: Now What?

One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.

CVX : 109.01 (-0.73%)
CVS : 71.51 (-0.60%)
AGN : 200.15 (+0.71%)
OXY : 42.12 (-1.98%)
ABBV : 94.96 (+0.77%)
Beth Fegan of FeganScott Law Firm Named Co-Lead Counsel in Allergan BIOCELL Class Action

Elizabeth A. Fegan, founder and managing partner of FeganScott, was named co-lead counsel in the U.S. district court class-action litigation involving Allergan, the manufacturers of BIOCELL textured and...

AGN : 200.15 (+0.71%)
Global Hospital Infection Therapeutics Market (2020 to 2025) - Key Players Include Merck & Co, Allergan & AstraZeneca Among Others - ResearchAndMarkets.com

The "Hospital Infection Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

AGN : 200.15 (+0.71%)
Global Gastrointestinal Therapeutics Market Witness Highest Growth in near future| Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals International company and Allergan plc

Global Gastrointestinal Therapeutics Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property...

ABT : 87.45 (-1.14%)
AGN : 200.15 (+0.71%)
AZN : 50.17 (+2.51%)
BAYRY : 20.0699 (-0.79%)
GSK : 43.08 (+0.75%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Facial Injectors Market - Global Industry Outlook, Share, Growth Analysis, Trends and Forecast 2020 - 2025

A new research study has been presented by ORBIS RESEARCH after a comprehensive analysis on Global Facial Injectors Market where user can get benefits from the complete market research report with all...

AGN : 200.15 (+0.71%)
MRK : 82.34 (-0.18%)
RVNC : 27.81 (+0.83%)
VRX.TO : 30.80 (-3.33%)
Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020

https://mma.prnewswire.com/media/222796/allergan_plc_logo.jpg

AGN : 200.15 (+0.71%)
Ironwood (IRWD) Surpasses Q4 Earnings and Sales Estimates

Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter as well. Stock up.

IRWD : 11.63 (-3.16%)
AZN : 50.17 (+2.51%)
AGN : 200.15 (+0.71%)
CYCN : 4.61 (-13.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 201.92
1st Resistance Point 201.03
Last Price 200.15
1st Support Level 198.63
2nd Support Level 197.12

See More

52-Week High 202.21
Last Price 200.15
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar